Literature DB >> 2535059

Biochemical identification of I-J as a novel dimeric surface molecule on mouse helper and suppressor T cell clones.

T Nakayama1, R T Kubo, H Kishimoto, Y Asano, T Tada.   

Abstract

A monoclonal anti-I-Jk antibody JK10-23 was capable of precipitating the putative I-Jk molecule from NP-40 lysates of 125I-surface labelled mouse T cell clones with either helper or suppressor functions. The I-J molecule detected by specific immunoprecipitation and subsequent one- or two-dimensional gel analysis was a Mr 84-90 K dimer composed of 42-46 K glycopeptide subunits having isoelectric point pH 5.3 to 6.4. A monomeric form of I-J also existed in some of the T cell clones. The I-J subunit was a glycosylated polypeptide with a 41 K backbone having at least two glycosylation sites. I-J was distinguishable from other known dimeric T cell surface molecules with comparable molecular size, that is, T cell receptor alpha beta heterodimer, A1 and YE molecules expressed on a T cell leukemia EL4, and mouse CD28. The I-Jk molecule was precipitable from T cell clones with I-Ak and I-Ek restriction specificities including a clone derived from an H-2b----H-2bxkF1 radiation bone marrow chimera. None of the H-2b-restricted T cell clones from H-2b and its F1 showed the I-Jk immunoreactivity. T cell clones having either I-Ab or I-Ek restriction specificities derived from intra-H-2 recombinant mouse B10.A(5R) were positive for the I-Jk, while an I-Ab-restricted T cell clone from B10.A(3R) was negative in the I-Jk immunoprecipitation. The results indicate that I-J is a novel dimeric surface molecule, most likely to be a homodimer, expressed on T cells according to the major histocompatibility complex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535059     DOI: 10.1093/intimm/1.1.50

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  3 in total

1.  Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.

Authors:  T Nakano; Y C Liu; T Mikayama; H Watarai; M Taniguchi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

2.  A novel type of cell death of lymphocytes induced by a monoclonal antibody without participation of complement.

Authors:  S Matsuoka; Y Asano; K Sano; H Kishimoto; I Yamashita; H Yorifuji; M Utsuyama; K Hirokawa; T Tada
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

3.  Physical dissociation of the TCR-CD3 complex accompanies receptor ligation.

Authors:  H Kishimoto; R T Kubo; H Yorifuji; T Nakayama; Y Asano; T Tada
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.